Stocktoria
Qiagen N.V. QIA.DE
Qiagen N.V. (QIA.DE) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.78% (safety: safe). FY2025 revenue was $2.1B at a 20.3% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 23 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.236 |
| Retained earnings / assets | 0.438 |
| EBIT / assets | 0.083 |
| Equity / liabilities | 1.509 |
FAQ
Is QIA.DE financially healthy?
Qiagen N.V.'s Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does QIA.DE pay a dividend, and is it safe?
Yes. Qiagen N.V. pays a dividend yielding about 0.78% with a 12.8% payout ratio, rated “safe” for safety.
How profitable is QIA.DE?
In FY2025, Qiagen N.V. had a net margin of 20.3% and a return on equity of 11.2%.
Source: company filings via Yahoo Finance · DE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.